Skip to main contentSkip to navigation
Sirius Investors
BioPorto A/S

BioPorto A/S

THOXF
OTCHealthcare

BioPorto A/S (THOXF) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate BioPorto A/S's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
-6.80
Burn Risk
P/B Ratio
8.70
Weak
WeakModerateStrong
Earnings Yield
-14.98%
Yield Gap

Profitability Health

2025
Return on Equity
-130.33%
Weak
WeakModerateStrong
Operating Margin
-213.70%
Weak
WeakModerateStrong
Net Profit Margin
-203.83%
Weak
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
10.91%
Strong
WeakModerateStrong
Net Income Growth
-20.06%
Weak
WeakModerateStrong
EPS Growth
11.76%
Moderate
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
3.25
Strong
WeakModerateStrong
Quick Ratio
2.90
Strong
WeakModerateStrong
Asset Turnover
0.43x
Weak
WeakModerateStrong
Inventory Turnover
1.33x
Weak
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
-14.06%
Weak
WeakModerateStrong
EV / Free Cash Flow
-6.50x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.56x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.018
Strong
WeakModerateStrong
Return on Invested Capital
-114.38%
Weak
WeakModerateStrong
Cash Conversion Cycle
-45.87 days
Strong
WeakModerateStrong

Fortress screener guardrails

2/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for THOXF.

View Financial Statements